Literature DB >> 3356359

Risk factors for healing of duodenal ulcer under antacid treatment: do ulcer patients need individual treatment?

S Massarrat1, H G Müller, P Schmitz-Moormann.   

Abstract

In order to identify the risk factors affecting the healing of duodenal ulcer, a clinical trial with effective dose of antacid was carried out in 53 patients. Duration of ulcer history, number of relapses, duration of the last and present relapse, number, duration and severity of pain attacks in the present ulcer relapse, pain radiation to back, vomiting, appetite, smoking habit, intake of analgesics and previous haemorrhage were registered. Number of ulcers, ulcer depth, bublar narrowing, erosions, duodenitis at initial endoscopy and healing of ulcer were assessed by one endoscopist. Basic and peak acid output were measured. The extent of duodenitis on the site opposite the ulcer was determined by histological examination. Sixty per cent of the duodenal ulcers were healed after three weeks. By univariate analysis, the following factors affect the healing; pain radiation to back and pain duration during treatment (p less than 0.001), multiple or deep ulcers, narrowing of duodenal bulb (p less than 0.01), number of pain attacks and poor appetite (p less than 0.05). By the stepwise logistic regression model, the following factors were selected as predictors for healing of duodenal ulcer with 76% correct classification: pain radiation to back (p = 0.002), deep ulcer (p = 0.013), multiple ulcers (p = 0.028). Number of cigarettes/day (p less than 0.007) and male sex (p = 0.036). By this model, the prediction of healing could be accurately assessed in 78% in a new sample. Individual treatment should be carried out on the basis of these factors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3356359      PMCID: PMC1433618          DOI: 10.1136/gut.29.3.291

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

1.  Healing of duodenal ulcer with an antacid regimen.

Authors:  W L Peterson; R A Sturdevant; H D Frankl; C T Richardson; J I Isenberg; J D Elashoff; J Q Sones; R A Gross; R W McCallum; J S Fordtran
Journal:  N Engl J Med       Date:  1977-08-18       Impact factor: 91.245

2.  Women and duodenal ulcer.

Authors:  N R Peden; E J Boyd; K G Wormsley
Journal:  Br Med J (Clin Res Ed)       Date:  1981-03-14

3.  Gastric acid secretion, smoke and duodenal ulcer healing.

Authors:  G Bianchi Porro; A Prada; M Petrillo; M Lazzaroni
Journal:  Gastroenterology       Date:  1982-02       Impact factor: 22.682

4.  Influence of smoking on healing rate of duodenal ulcer in response to cimetidine or high-dose antacid.

Authors:  M G Korman; R G Shaw; J Hansky; G T Schmidt; A I Stern
Journal:  Gastroenterology       Date:  1981-06       Impact factor: 22.682

5.  Effect of smoking on duodenal ulcer healing with cimetidine and oxmetidine.

Authors:  R Gugler; H G Rohner; P Kratochvil; G Brandstätter; H Schmitz
Journal:  Gut       Date:  1982-10       Impact factor: 23.059

6.  Treatment of duodenal ulcer with low-dose antacids.

Authors:  G Lux; H Hentschel; H G Rohner; H Brunner; K Schütze; P C Lederer; W Rösch
Journal:  Scand J Gastroenterol       Date:  1986-11       Impact factor: 2.423

7.  Trimipramine in the treatment of duodenal ulcer. A multicenter, open study.

Authors:  K Valnes; S Wetterhus; E Ellekjaer; L Halvorsen; N Hovdenak; S Larsen; O E Skaug; M Tønder; J Myren
Journal:  Scand J Gastroenterol Suppl       Date:  1980

8.  Cimetidine and duodenal ulcer: an analysis of methodologic problems in randomized controlled trials.

Authors:  J J Chuong; H M Spiro
Journal:  J Clin Gastroenterol       Date:  1982-08       Impact factor: 3.062

9.  Factors affecting the healing rate of duodenal and pyloric ulcers with low-dose antacid treatment.

Authors:  S Massarrat; A Eisenmann
Journal:  Gut       Date:  1981-02       Impact factor: 23.059

10.  Predictors of duodenal ulcer healing and relapse.

Authors:  A Sonnenberg; S A Müller-Lissner; E Vogel; P Schmid; J J Gonvers; P Peter; G Strohmeyer; A L Blum
Journal:  Gastroenterology       Date:  1981-12       Impact factor: 22.682

View more
  4 in total

Review 1.  Prescribing policy for antiulcer treatment in the elderly.

Authors:  G Bianchi Porro; M Lazzaroni
Journal:  Drugs Aging       Date:  1993 Jul-Aug       Impact factor: 3.923

2.  Predictors of duodenal ulcer healing during treatment with cimetidine.

Authors:  M Okada; T Yao; K Maeda; T Yamamoto; K Saigenji; Y Okada; K Sakamoto; K Tanaka
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

3.  Prospective multicentre study of risk factors associated with delayed healing of recurrent duodenal ulcers (RUDER). RUDER Study Group.

Authors:  D Armstrong; R Arnold; M Classen; M Fischer; H Goebell; A L Blum
Journal:  Gut       Date:  1993-10       Impact factor: 23.059

4.  Mucosal Healing Effectiveness and Safety of Anaprazole, a Novel PPI, vs. Rabeprazole in Patients With Duodenal Ulcers: A Randomized Double-Blinded Multicenter Phase II Clinical Trial.

Authors:  Xu Shu; Zhenhua Zhu; Yu Fu; Zhenyu Zhang; Jiangbin Wang; Xing Li; Shuixiang He; Huizhen Fan; Side Liu; Guoxin Zhang; Jianhua Tang; Caibin Huang; Qin Du; Xiaoyan Wang; Baohong Xu; Yiqi Du; Qikui Chen; Bangmao Wang; Ying Chen; Xianghui Duan; Yong Xie; Lijuan Huo; Xiaohua Hou; Nonghua Lu
Journal:  Front Med (Lausanne)       Date:  2021-07-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.